优德88

News

Your Current Position: News > Company News

12

2020-08

【Company News】 Ceftriaxone sodium, the major product of the company, was certified by Brazil ANVISA
02

2018-04

【Company News】 The company fluoxetine for the treatment of pigment decolorization disease application project were authorized
18

2018-01

【Company News】 The wind and rain together to write the Spring and Autumn, to join hands and create brilliant! - Warmly celebrate the 27th anniv
28

2017-11

【Company News】 The company participated in the 78th China pharmaceutical fair
29

2017-09

【Company News】 Shandong Province Safety Production Second Inspection Team Visits Ruiying to Inspect and Guide Safety Production Work
10

2017-04

【Company News】 Ruiying Pioneer Intellectual Property Management System Certification Successfully Completed
09

2016-08

【Company News】 Four kind of sterile bulk drug product are approved by the national GMP certification
10

2015-07

【Company News】 Ceftriaxone sodium, the major product of the company, was certified by Brazil ANVISA
10

2015-04

【Company News】 Five kind of sterile bulk drug product and fourteen bulk drug product are approved by the national GMP certification
02

2014-07

【Company News】 A production technology of the company was granted national invention patent

First <Previous 1 2 3 4 5 6 7 8 9 ... Next> End

About Us

Company profile
Company culture
CEO speech
Corporate honors
Company strength
Structure
Global layout
Marketing network

Products

Cephalosporin
Penicillin series
Intermediate
Anti tumor series
Big health Series
Latest products

News

Company News
Industry News

Environmental protection

Self monitoring
EIA publicity
Third party testing

Contact Us

Address: No. 1777 Kunming Road, Mudan District, Heze City, Shandong Province
phones：400-6050-616
Email：

Wechat

© 2024 Shandong Ruiying Pioneer Pharmaceutical Co.,Ltd. ICP Number 10040251-1

鲁ICP备10040251号-1

TOP

0530-5852366

qrCode

sales@rychem.com

XML地图